Naturalendo Tech Co

Naturalendo Tech Co R&D per Employee

The R&D Spending per Employee of Naturalendo Tech Co (168330.KQ) as of Nov 10, 2026 is 31.28 M KRW. In the previous year, R&D Spending per Employee was 32.63 M KRW — a change of -4.14% (lower).

R&D per Employee

31.28 MKRW

YoY

-4.14%

Last updated:

R&D Spending per Employee of Naturalendo Tech Co is 2025 31.28 M KRW. R&D Spending per Employee of Naturalendo Tech Co was 2024 32.63 M KRW. It decreases by -4.14% lower compared to the previous year.

The Naturalendo Tech Co R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2018
33.14 M KRW
Jan 1, 2019
30.22 M KRW
Jan 1, 2020
20.53 M KRW
Jan 1, 2021
22.95 M KRW
Jan 1, 2022
27.56 M KRW
Jan 1, 2023
30.50 M KRW
Jan 1, 2024
32.63 M KRW
Jan 1, 2025
31.28 M KRW
The Naturalendo Tech Co R&D per Employee history
YEARR&D per EmployeeYoY
31.28 MKRW-4.14%
32.63 MKRW+6.99%
30.50 MKRW+10.67%
27.56 MKRW+20.07%
22.95 MKRW+11.82%
20.53 MKRW-32.08%
30.22 MKRW-8.80%
33.14 MKRW+48.00%
22.39 MKRW+12.39%
19.92 MKRW-37.58%
31.92 MKRW+13.67%
28.08 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Naturalendo Tech Co Stock analysis

What does Naturalendo Tech Co do? Naturalendo Tech Co., Ltd. generates revenue by engaging in the physical, chemical, and biological research and development of healthcare materials, specifically focusing on hormone biotechnology products. The Korea-based company manufactures novel phytoestrogen, which is applied in the treatment of climacteric, as well as other hormonal formulas including hormone disruptor inhibitors, secretagogues, and inhibitors used as diet formulas and growth hormone. The firm also provides materials used for diet and involves itself in the research and development of drug delivery systems, immune enhancers, and treatments for atopy and acne. The company further monetizes its expertise by developing solutions for plantation factories and other related areas within the healthcare sector. Headquartered in Seongnam, Gyeonggi-Do, Naturalendo Tech Co., Ltd. serves clients seeking advanced biotechnology applications in dietary and medical treatments. The business model relies on its proprietary R&D capabilities to produce specialized hormonal and dietary materials, catering to the demand for innovative healthcare solutions in the biotechnology industry. Naturalendo Tech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Naturalendo Tech Co stock

R&D Spending per Employee of Naturalendo Tech Co is 31.28 M KRW in 2025.

R&D Spending per Employee of Naturalendo Tech Co changed from 32.63 M KRW to 31.28 M KRW, representing a -4.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Naturalendo Tech Co since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Naturalendo Tech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — Naturalendo Tech Co

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Naturalendo Tech Co